| Jacqueline Lewis-lyons, PSYD | |
|
3591 Reserve Commons Dr, Suite 301, Medina, OH 44256-5334 | |
| (330) 764-7916 | |
| (330) 723-6399 |
| Full Name | Jacqueline Lewis-lyons |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3591 Reserve Commons Dr, Medina, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316098189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 4992 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Lewis-lyons, PSYD 3591 Reserve Commons Dr, Suite 301, Medina, OH 44256-5334 Ph: (330) 764-7916 | Jacqueline Lewis-lyons, PSYD 3591 Reserve Commons Dr, Suite 301, Medina, OH 44256-5334 Ph: (330) 764-7916 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin® Capsules used to treat a painful complication of shingles.
The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with "low T" is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One.
Are you suffering from heartburn? Heartburn can be a symptom of a serious problem called "gastroesophageal reflux disease," also known as GERD.
Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.
› Verified 4 days ago
Dr. Nancy P. Taylor, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3591 Reserve Commons Dr, Suite 301, Medina, OH 44256 Phone: 330-764-7916 | |
Megan Schaecher-pecek, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3591 Reserve Commons Dr, Suite 301, Medina, OH 44256 Phone: 330-764-7916 Fax: 330-723-6399 | |
Seth T Krieger, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3591 Reserve Commons Dr, Suite 301, Medina, OH 44256 Phone: 330-764-7916 Fax: 330-723-6933 | |
Stacey Ilko - Hancock, PSY.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 221 W Liberty St, Medina, OH 44256 Phone: 330-722-4166 Fax: 330-725-5792 | |
Dr. Peter Arian, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 S. Court St., Medina, OH 44256 Phone: 330-723-7977 | |
Amy Thatcher-benza, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4018 Medina Rd Ste D, Medina, OH 44256 Phone: 330-722-4166 Fax: 330-725-5792 | |
Dr. Sarah Toman, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6636 River Styx Rd, Medina, OH 44256 Phone: 330-723-4293 Fax: 330-764-3485 |